All Stories

  1. Moving towards a systems-based classification of innate immune-mediated diseases
  2. ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
  3. Tumour necrosis factor signalling in health and disease
  4. Cellular stress, with activation of unfolded protein response (UPR) and microRNA, in disease.
  5. Corticosteroid transdermal delivery significantly improves arthritis pain and functional disability
  6. Protection against lupus-like inflammatory disease is in the LAP of non-canonical autophagy
  7. The burgeoning field of innate immune-mediated disease and autoinflammation
  8. Autoinflammatory diseases: update on classification diagnosis and management
  9. Faculty of 1000 evaluation for In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity.
  10. Faculty of 1000 evaluation for Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis.
  11. Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond
  12. Clinical genetics in 2014: New monogenic diseases span the immunological disease continuum
  13. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
  14. TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes
  15. IL-17A RNA Aptamer: Possible Therapeutic Potential in Some Cells, More than We Bargained for in Others?
  16. First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
  17. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
  18. Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene
  19. OR10-002 - A novel TNFR1 transcript of TRAPS gene
  20. OR10-004 - Circulating micrornas in TRAPS
  21. PW02-013 - The role of IL6 and LPS in pathogenesis of TRAPS
  22. Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients
  23. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives
  24. Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome
  25. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients
  26. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases
  27. Anti-TNF Treatment in Rheumatoid Arthritis
  28. Is caspase 1 central to activation of interleukin-1?
  29. Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome
  30. The role of the NLRP3 inflammasome in gout
  31. Inflammasomes and autoimmunity
  32. Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients
  33. Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes
  34. Lessons from Anti-TNF Biologics: Infliximab Failure in a TRAPS Family with the T50M Mutation in TNFRSF1A
  35. Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients
  36. Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes
  37. The NLRP3 inflammasome, a target for therapy in diverse disease states
  38. Periodic fever syndrome and autoinflammatory diseases
  39. Imaging evidence for persistent subclinical fasciitis and arthritis in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) between febrile attacks
  40. Inflammation: Canakinumab for the cryopyrin-associated periodic syndromes
  41. p38MAPK: stress responses from molecular mechanisms to therapeutics
  42. Proteolytic Activation of the Cytotoxic Phenotype during Human NK Cell Development
  43. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response
  44. An Integrated Classification of Pediatric Inflammatory Diseases, Based on the Concepts of Autoinflammation and the Immunological Disease Continuum
  45. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome
  46. Rilonacept in the treatment of chronic inflammatory disorders
  47. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) or Familial Hibernian Fever
  48. Rilonacept in cryopyrin-associated periodic syndromes: the beginning of longer-acting interleukin-1 antagonism
  49. Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)
  50. Fifth International Congress on Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
  51. Successful treatment of resistant pseudogout with anakinra
  52. Primer: inflammasomes and interleukin 1β in inflammatory disorders
  53. NOD-like receptors and inflammation
  54. A novel TNFRSF1A splice mutation associated with increased nuclear factor  appaB (NF- B) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)
  55. Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra
  56. The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self
  57. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases
  58. Abnormal tumor necrosis factor receptor I cell surface expression and NF-κB activation in tumor necrosis factor receptor–associated periodic syndrome
  59. A Proposed Classification of the Immunological Diseases
  60. Hereditary auto-inflammatory disorders and biologics
  61. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism
  62. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-κB activation
  63. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study
  64. The EIF2AK3 gene region and type I diabetes in subjects from South India
  65. Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement
  66. A common pathway in periodic fever syndromes
  67. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis
  68. The major histocompatibility complex origin
  69. NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
  70. Periodic fever due to a novel TNFRSF1A mutation in a heterozygous Chinese carrier of MEFV E148Q
  71. Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease
  72. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra
  73. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes
  74. Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
  75. Genetic clues to understanding periodic fevers, and possible therapies
  76. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept
  77. The autoinflammatory syndromes
  78. SPINK1 Is a Susceptibility Gene for Fibrocalculous Pancreatic Diabetes in Subjects from the Indian Subcontinent
  79. Association of mutations in theNALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis
  80. Cytokine gene polymorphism in human disease: on-line databases, Supplement 2
  81. Genetics of type 1 diabetes mellitus
  82. Vitamin D Receptor (VDR) mRNA and VDR Protein Levels in Relation to Vitamin D Status, Insulin Secretory Capacity, and VDR Genotype in Bangladeshi Asians
  83. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever
  84. Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study
  85. An Israeli Arab patient with a de novoTNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome
  86. Hereditary periodic fever syndromes
  87. Cytokine gene polymorphism in human disease: on-line databases, Supplement 1
  88. Tumour necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families
  89. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance
  90. An autosomal dominant periodic fever associated with AA amyloidosis in a North Indian family maps to distal chromosome 1q
  91. TNFRSF1A mutations and autoinflammatory syndromes
  92. Family association studies of markers on chromosome 2q and Type 1 diabetes in subjects from South India
  93. Pancreatitis in fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene
  94. Cytokine gene polymorphism in human disease: on-line databases
  95. Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes
  96. The MHC Big Bang
  97. B30.2-like domain proteins: update and new insights into a rapidly expanding family of proteins
  98. Linkage of Familial Hibernian Fever to Chromosome 12p13
  99. Exclusion of the familial Mediterranean fever locus as a susceptibility region for autosomal dominant familial Hibernian fever.
  100. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians
  101. Modelling the major histocompatibility complex susceptibility to RA using the MASC method
  102. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians